Cell Therapy Market

Cell Therapy Market by Use Type (Clinical Use and Research Use), by Therapy Type (Autologous, and Allogenic), by Therapeutic Area (Malignancies, Musculoskeletal Disorder, Autoimmune Disorder, Dermatology and Other), by End User (Hospital & Clinic and Academic and Research Institute) – Global Outlook & Forecast 2022-2030

GR - 748748 Category: Pharmaceuticals

Number of pages: 100 | Report Format: PDF | Published date: November 04, 2022

Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030

Cell Therapy Market Scope

Report Attribute	Details
Market size value in 2021	US$ 9.4 billion
Revenue forecast in 2030	US$ 21.80 billion
Growth Rate	CAGR of 10% from 2022 to 2030
Base year for estimation	2021
Forecast period	2022-2030
Segments covered	Cell Type, Therapy Type, Therapeutic Area, End User and Region.
Regional scope	North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

The global cell therapy market was pegged at US$ 9.4 billion in 2021 and is expected to witness a CAGR of 10% during the forecast period.

Market Fundamental

Cell therapy involves implanting cells into patients' bodies to treat certain illnesses. These cells might be autologous, which means they come from the patient's body, or allogeneic, which means they come from another donor. While multipotent cells can also convert into other cell types, their repertoire is less extensive than that of pluripotent cells, which can transform into every type of cell in the body. It is a set form of cell for primary cells. Depending on the type of treatment, different cell types are used. When replacing cells, stem cells or cells produced from stem cells are employed in stem cell treatment, a type of cell therapy.

[8684358]

Market Dynamic

The market is primarily driven by the increase in cell-based therapy clinical investigations. As a result, there has been a large global investment in research and its clinical application. The existence of public and private financing organisations, which frequently provide funds to support initiatives across multiple stages of clinical trials, can be credited with the rise in the number of ongoing clinical trials.

Market Ecosystem

The global market has been analysed from five perspectives by cell type, therapy type, therapeutic area, end user and region.

Cell Therapy Market by Use Type

[2134324]

Based on use type, the global cell therapy market has been segmented into clinical and research use. The research segment dominated the market during forecast period due to its application for scientific purposes. The segment is expanding as a result of the expanding R&D initiatives. Additionally, major market participants are heavily funding research initiatives. Governmental organisations are working together on research projects involving cells, in addition to market participants. These elements collectively are fueling the segment's expansion.

Cell Therapy Market by Therapy Type

Based on therapy type, the global cell therapy market has been segmented into autologous, and allogenic. The allogeny segment dominates the segment during forecast period and this trend will continue to dominate the during the whole forecast period due to the treatment's capacity to get beyond the drawbacks of the autologous CAR T-cell paradigm, like the difficulties of leukapheresis, and offer effective and widely available CAR therapies.

Cell Therapy Market by Therapeutic Area

Based on therapeutic area, the global cell therapy market has been segmented into malignancies, musculoskeletal disorder, autoimmune disorder, dermatology and other. The autoimmune disorder dominated the segment during forecast period. More than 40% of current treatments use cell therapy as a potential cure for diseases like cancer, autoimmune disorders, and other infectious diseases. The most popular cell therapy in both North America and many Asian countries is hematopoietic stem cell transplantation.

Cell Therapy Market by End User

Based on end user, the global cell therapy market has been segmented into hospital & clinic and academic and research institute. The academic and research institute dominated the segment during forecast period. Stem cells have a large market share in the technological industry and are typically used in research initiatives. The ability to replace, mend, regenerate, or repair damaged tissues, cells, and organs is a significant advantage of cell-based therapies. As an alternative to conventional treatment approaches, researchers are heavily investing in the development of such efficient and secure remedies.

Cell Therapy Market by Region

Based on region, the global cell therapy market has been segmented into North America, Europe, Asia Pacific, Rest of the World. North America is anticipated to have the largest market share. The region's significant market share can be ascribed to the existence of numerous centres and institutes working on stem cell treatment research and development. The Institute for Stem Cell Biology and Regenerative Medicine at Stanford University, the Harvard Stem Cell Institute at Harvard University, the Yale Stem Cell Center, and the Institute for Stem Cell Biology and Regenerative Medicine are among the top eight universities in the world.

Cell treatment is predicted to see a profitable growth rate in Asia Pacific throughout the forecast period. Revenue from the emerging economies of this region is expected to increase as a result of the rising investments made by both innovators and consumers in educating themselves about sophisticated medical therapies. A number of stem cell consortiums exist in Asian nations with the goal of assuring coordinated and targeted R&D initiatives. Due of the accommodating legal systems, patients from western nations are also known to travel to Asia for medical treatment.

Competitive Landscape

Some of the prominent market player in the global cell therapy market include

Kolon TissueGene, Inc.
Anterogen Co., Ltd.
JCR Pharmaceuticals Co., Ltd.
Thermo Fisher Scientific Inc.
Castle Creek Biosciences, Inc.
Osiris Therapeutics, Inc.
PHARMICELL Co., Ltd
Merck KGaA
Tameika Cell Technologies, Inc.
Cells for Cells
NuVasive, Inc.
Lonza Group
Vericel Corporation
Celgene Corporation
Medipost

Strategic Development

In March 2022, following its successful entry into the European market, the Korean stem cell therapy company Miracell is getting ready to expand into the Middle East. The chief executive of the company claimed that videoconferencing with potential customers in the Middle East takes up all of the company's afternoons. Since its founding in 2009, Miracell has operated in the fields of stem cell therapy, cosmetics, medical equipment, and cell banking.
In February 2022, Thermo Fisher Scientific has announced the introduction of new integrated commercial packaging and distribution services designed to help patients in Europe and the United States transition from receiving medications in clinics to using them on the market. Developers need the most recent Patheon Commercial Packaging Services, an end-to-end solution combining global distribution, GMP storage, ultracold & cryogenic packaging, and serialisation.

Frequently Asked Questions About This Report

The global cell therapy market is expected to clock US$ 21.80 billion by 2030.

The global cell therapy market was pegged is expected to witness a CAGR of 10% during the forecast period.

Some of the prominent market player in the global cell therapy market include Kolon TissueGene, Inc., Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., Thermo Fisher Scientific Inc., Castle Creek Biosciences, Inc. and others.

The research segment led the global cell therapy market

Cell therapy is a sort of therapy in which a patient receives an injection of live cells to treat a variety of ailments by swapping out unhealthy or defective cells with healthy ones.

Table of Content

INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
  1. Historical Years - 2020
  2. Base Years - 2021
  3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
  1. Secondary Sources
  2. Primary Sources
4. Market Estimation Approach
  1. Bottom Up
  2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
1. Drivers
2. Restraints/Challenges
3. Opportunities
GLOBAL CELL THERAPY MARKET - ANALYSIS & FORECAST, BY USE TYPE
1. Clinical Use
2. Research Use
GLOBAL CELL THERAPY MARKET - ANALYSIS & FORECAST, BY THERAPY TYPE
1. Autologous
2. Allogenic
GLOBAL CELL THERAPY MARKET - ANALYSIS & FORECAST, BY THERAPEUTIC AREA
1. Malignancies
2. Musculoskeletal Disorder
3. Autoimmune Disorder
4. Dermatology
5. Other
GLOBAL CELL THERAPY MARKET - ANALYSIS & FORECAST, BY END USER
1. Hospital & Clinic
2. Academic
3. Research Institute
GLOBAL CELL THERAPY MARKET - ANALYSIS & FORECAST, BY REGION
1. North America Cell Therapy Market
  1. North America Cell Therapy Market, by Use Type
  2. North America Cell Therapy Market, by Therapy Type
  3. North America Cell Therapy Market, by Therapeutic Area
  4. North America Cell Therapy Market, by End User
  5. North America Cell Therapy Market, by Country
    1. U.S.
      1. U.S. Cell Therapy Market, by Use Type
      2. U.S. Cell Therapy Market, by Therapy Type
      3. U.S. Cell Therapy Market, by Therapeutic Area
      4. U.S. Cell Therapy Market, by End User
    2. Canada
      1. Canada Cell Therapy Market, by Use Type
      2. Canada Cell Therapy Market, by Therapy Type
      3. Canada Cell Therapy Market, by Therapeutic Area
      4. Canada Cell Therapy Market, by End User
2. Europe Cell Therapy Market
  1. Europe Cell Therapy Market, by Use Type
  2. Europe Cell Therapy Market, by Therapy Type
  3. Europe Cell Therapy Market, by Therapeutic Area
  4. Europe Cell Therapy Market, by End User
  5. Europe Cell Therapy Market, by Country/Region
    1. Germany
      1. Germany Cell Therapy Market, by Use Type
      2. Germany Cell Therapy Market, by Therapy Type
      3. Germany Cell Therapy Market, by Therapeutic Area
      4. Germany Cell Therapy Market, by End User
    2. U.K.
      1. U.K. Cell Therapy Market, by Use Type
      2. U.K. Cell Therapy Market, by Therapy Type
      3. U.K. Cell Therapy Market, by Therapeutic Area
      4. U.K. Cell Therapy Market, by End User
    3. Spain
      1. Spain Cell Therapy Market, by Use Type
      2. Spain Cell Therapy Market, by Therapy Type
      3. Spain Cell Therapy Market, by Therapeutic Area
      4. Spain Cell Therapy Market, by End User
    4. Italy
      1. Italy Cell Therapy Market, by Use Type
      2. Italy Cell Therapy Market, by Therapy Type
      3. Italy Cell Therapy Market, by Therapeutic Area
      4. Italy Cell Therapy Market, by End User
    5. France
      1. France Cell Therapy Market, by Use Type
      2. France Cell Therapy Market, by Therapy Type
      3. France Cell Therapy Market, by Therapeutic Area
      4. France Cell Therapy Market, by End User
    6. Rest of Europe
      1. Rest of Europe Cell Therapy Market, by Use Type
      2. Rest of Europe Cell Therapy Market, by Therapy Type
      3. Rest of Europe Cell Therapy Market, by Therapeutic Area
      4. Rest of Europe Cell Therapy Market, by End User
3. Asia Pacific Cell Therapy Market
  1. Asia Pacific Cell Therapy Market, by Use Type
  2. Asia Pacific Cell Therapy Market, by Therapy Type
  3. Asia Pacific Cell Therapy Market, by Therapeutic Area
  4. Asia Pacific Cell Therapy Market, by End User
  5. Asia Pacific Cell Therapy Market, by Country/Region
    1. China
      1. China Cell Therapy Market, by Use Type
      2. China Cell Therapy Market, by Therapy Type
      3. China Cell Therapy Market, by Therapeutic Area
      4. China Cell Therapy Market, by End User
    2. Japan
      1. Japan Cell Therapy Market, by Use Type
      2. Japan Cell Therapy Market, by Therapy Type
      3. Japan Cell Therapy Market, by Therapeutic Area
      4. Japan Cell Therapy Market, by End User
    3. India
      1. India Cell Therapy Market, by Use Type
      2. India Cell Therapy Market, by Therapy Type
      3. India Cell Therapy Market, by Therapeutic Area
      4. India Cell Therapy Market, by End User
    4. South Korea
      1. South Korea Cell Therapy Market, by Use Type
      2. South Korea Cell Therapy Market, by Therapy Type
      3. South Korea Cell Therapy Market, by Therapeutic Area
      4. South Korea Cell Therapy Market, by End User
    5. Australia
      1. Australia Cell Therapy Market, by Use Type
      2. Australia Cell Therapy Market, by Therapy Type
      3. Australia Cell Therapy Market, by Therapeutic Area
      4. Australia Cell Therapy Market, by End User
    6. Rest of Asia Pacific
      1. Rest of Asia Pacific Cell Therapy Market, by Use Type
      2. Rest of Asia Pacific Cell Therapy Market, by Therapy Type
      3. Rest of Asia Pacific Cell Therapy Market, by Therapeutic Area
      4. Rest of Asia Pacific Cell Therapy Market, by End User
4. Rest of the World Cell Therapy Market
  1. Rest of the World Cell Therapy Market, By Region
    1. Rest of the World Cell Therapy Market, by Use Type
    2. Rest of the World Cell Therapy Market, by Therapy Type
    3. Rest of the World Cell Therapy Market, by Therapeutic Area
    4. Rest of the World Cell Therapy Market, by End User
    5. Latin America
      1. Latin America Cell Therapy Market, by Use Type
      2. Latin America Cell Therapy Market, by Therapy Type
      3. Latin America Cell Therapy Market, by Therapeutic Area
      4. Latin America Cell Therapy Market, by End User
    6. Middle East & Africa
      1. Middle East & Africa Cell Therapy Market, by Use Type
      2. Middle East & Africa Cell Therapy Market, by Therapy Type
      3. Middle East & Africa Cell Therapy Market, by Therapeutic Area
      4. Middle East & Africa Cell Therapy Market, by End User
COMPANY PROFILES
1. Kolon TissueGene, Inc.
  1. Business Snapshot
  2. Use Types/Services Offered
  3. Financial Details*
  4. Strategic Developments
2. Anterogen Co., Ltd.
3. JCR Pharmaceuticals Co., Ltd.
4. Thermo Fisher Scientific Inc.
5. Castle Creek Biosciences, Inc.
6. Osiris Therapeutics, Inc.
7. PHARMICELL Co., Ltd
8. Merck KGaA
9. Tameika Cell Technologies, Inc.
10. Cells for Cells
11. NuVasive, Inc.
12. Lonza Group
13. Vericel Corporation
14. Celgene Corporation
15. Medipost

*Insights on financial performance is subject to availability of information in public domain

Single User License

Multi User License

Enterprise User License

$4,750.00

What are the significant driving and restraining factors for the Cell Therapy Market?
Who are the leading companies in the market?
Where can you find the updates on recent developments by market players?
When is the right time to get discounts on complete market reports?
Why to invest in the Cell Therapy Market?
How to improve your organizational performance?
How to shift customers towards your brand?

Ask For Customization Check Discount Inquire Before Buying

Recommended Reports